We’re pleased to announce that two funding opportunities for the new Support for Research Excellence (SuRE) program, which replaces our Support of Competitive Research (SCORE) program, have been issued. SuRE R16 awards support investigator-initiated research projects in all NIH mission areas and are open to faculty at institutions that award science degrees (bachelor and/or graduate degrees), receive limited NIH research support, and serve students from groups underrepresented in biomedical research. Faculty with prior experience in leading independent research who aren’t currently program directors/principal investigators of active NIH research project grants may apply for a SuRE Award (PAR-21-169). Faculty who haven’t had any prior independent research grant support are encouraged to apply for the SuRE-First Award (PAR-21-173).

On December 27, 2020, the Consolidated Appropriations Act, 2021, was signed into law. The appropriation provides NIGMS with a budget of $2,991,417,000, in Fiscal Year (FY) 2021, a 1.8% increase over the FY 2020 appropriation. With this increased budget, NIGMS is committed to providing taxpayers with the best possible returns on their investments in fundamental biomedical research. As part of this commitment to stewardship, we regularly monitor trends in our funding portfolio.

NIGMS maintains a diversified biomedical research portfolio, supporting a wide range of topics and investigators. NIGMS and NIH programs and policies aim to increase the number of funded investigators and to maintain researchers’ funding stability over time. In this post, we describe NIGMS investigator-level trends for selected R01-equivalent grants as well as overall research project grant (RPG) trends for FY 2020 compared to previous fiscal years.

We’re pleased to announce a new notice of special interest (NOSI) calling for applications developing training modules for creating safe, inclusive, and supportive research environments (NOT-GM-20-047). The proposed modules should impact individuals from a broad range of scientific disciplines and career stages and cover material not typically taught as part of current institutional coursework. The modules can take many different formats and approaches and should be timely, informative, engaging, easily accessible, and free to everyone. Applications must address how the modules will catalyze either of the following:

I’m pleased to announce that Richard Aragon is the new director of the Institute's Division of Data Integration, Modeling, and Analytics (DIMA). He has been acting director of DIMA since January 2020.

Richard has ably led NIGMS’ strategic planning and evaluation activities and has served as our Congressional liaison since joining us in 2014 as chief of what was then our Office of Program Planning, Analysis, and Evaluation. In this role, he has evolved and expanded our capabilities to include predictive analytics, budget and fiscal modeling, and the use of artificial intelligence to enhance business processes. As we prepare to the launch the NIGMS 2021-2025 Strategic Plan this spring, Richard’s extensive expertise in spearheading these activities makes him the ideal candidate to lead this critical component of the Institute.

UPDATE: The video from this webinar is now available.

We’re pleased to announce the reissuance of funding opportunity announcements (FOAs) for the Undergraduate Research Training Initiative for Student Enhancement (U-RISE) (PAR-21-146) and the Maximizing Access to Research Careers (MARC) (PAR-21-147) T34 programs. The FOAs continue the shared goal to develop a diverse pool of undergraduates who complete their baccalaureate degree, and transition into and complete biomedical, research-focused higher degree programs (e.g., Ph.D. or M.D./Ph.D.).

The first application due date for these FOAs is May 26, 2021, and the earliest start date for both programs is April 2022.

We’re pleased to announce our Medical Scientist Training Program (MSTP) (T32) funding opportunity announcement (FOA) has been reissued (PAR-21-189). This FOA continues our efforts toward changes in integrated medical and graduate research training to keep pace with the rapidly evolving research environment that’s increasingly complex, interdisciplinary, quantitative, and collaborative. This program provides support to eligible domestic institutions to develop and implement effective, evidence-informed approaches to integrated dual-degree training leading to the award of both clinical degrees (e.g., M.D., D.O., D.V.M., D.D.S., and Pharm.D.), and research doctorate degrees (Ph.D.).

UPDATE: The video from this webinar is now available.

NIGMS is committed to increasing biomedical research capacity, including at institutions where faculty have significant teaching responsibilities. In these settings, research collaborations across institutions can be especially beneficial. Join us as we explore this topic:

Thursday, March 25, 3:00-4:00 p.m. ET

We’re pleased to announce the availability of administrative supplements to the Institutional Development Awards (IDeA). We invite eligible investigators to submit proposals in response to the following notices:

The search is underway for a critically important position on the NIGMS leadership team: our deputy director. The deputy director assists me in managing the Institute, advises on a range of topics, and handles special projects. This person also works closely with groups within and outside NIH and represents us on various federal and nonfederal scientific and professional committees.

We’re pleased to announce the availability of supplements to active INBRE (P20), COBRE (P20, P30), IDeA-CTR (U54), and NARCH (S06) awards to support vaccine hesitancy research relevant to SARS-CoV-2. The supplements are aimed at studying the causes of SARS-CoV-2 vaccine hesitancy in IDeA states and/or American Indian/Alaska Native communities, and at developing innovative evidence-based interventions to enhance vaccine acceptance with the goal of increased vaccine uptake.

Applications are due by April 30, 2021; see NOT-GM-21-021 for additional details.

If you have any questions about this supplement opportunity, please contact me.